Cargando…

Multiregional genetic evolution of metastatic uveal melanoma

Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and leads to deadly metastases for which there is no approved treatment. Genetic events driving early tumor development are well-described, but those occurring later during metastatic progression remain poorly understood...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez, Daniel A., Yang, Jessica, Durante, Michael A., Shoushtari, Alexander N., Moschos, Stergios J., Wrzeszczynski, Kazimierz O., Harbour, J. William, Carvajal, Richard D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8368296/ https://www.ncbi.nlm.nih.gov/pubmed/34400647 http://dx.doi.org/10.1038/s41525-021-00233-5

Ejemplares similares

The genetic evolution of metastatic uveal melanoma
por: Shain, A. Hunter, et al.
Publicado: (2019)

Genomic evolution of uveal melanoma arising in ocular melanocytosis
por: Durante, Michael A., et al.
Publicado: (2019)

Punctuated evolution of canonical genomic aberrations in uveal melanoma
por: Field, Matthew G., et al.
Publicado: (2018)

Impact of Genetic Ancestry on Prognostic Biomarkers in Uveal Melanoma
por: Rodriguez, Daniel A., et al.
Publicado: (2020)

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
por: Khan, Shaheer, et al.
Publicado: (2022)

Specific human endogenous retroviruses predict metastatic potential in uveal melanoma
por: Bendall, Matthew L., et al.
Publicado: (2022)

Single-cell analysis reveals new evolutionary complexity in uveal melanoma
por: Durante, Michael A., et al.
Publicado: (2020)

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas
por: Field, Matthew G., et al.
Publicado: (2016)

PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023)

Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma
por: Damato, Bertil E., et al.
Publicado: (2019)

Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution
por: Brouwer, Niels J., et al.
Publicado: (2019)

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
por: Wei, Alexander Z., et al.
Publicado: (2022)

Adjuvant crizotinib in high-risk uveal melanoma following definitive therapy
por: Khan, Shaheer, et al.
Publicado: (2022)

HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma
por: Sriramareddy, Sathya Neelature, et al.
Publicado: (2022)

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
por: Najjar, Yana G, et al.
Publicado: (2020)

Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment
por: Gezgin, Gülçin, et al.
Publicado: (2017)

Metastatic disease from uveal melanoma: treatment options and future prospects
por: Carvajal, Richard D, et al.
Publicado: (2017)

Treatment of Metastatic Uveal Melanoma: Systematic Review
por: Rodriguez-Vidal, Cristina, et al.
Publicado: (2020)

The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma
por: Harbour, J. William, et al.
Publicado: (2013)

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma
por: Matatall, Katie A, et al.
Publicado: (2013)

TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma
por: Strobel, Sophia B., et al.
Publicado: (2022)

Clinical and molecular response to tebentafusp in previously treated patients with metastatic uveal melanoma: a phase 2 trial
por: Carvajal, Richard D., et al.
Publicado: (2022)

Treatment of uveal melanoma: where are we now?
por: Yang, Jessica, et al.
Publicado: (2018)

Pilot Trial of Arginine Deprivation Plus Nivolumab and Ipilimumab in Patients with Metastatic Uveal Melanoma
por: Kraehenbuehl, Lukas, et al.
Publicado: (2022)

EMT-associated factors promote invasive properties of uveal melanoma cells
por: Asnaghi, Laura, et al.
Publicado: (2015)

Long-Term Survivors with Metastatic Uveal Melanoma
por: Buzzacco, Dominic M, et al.
Publicado: (2012)

Novel treatment paradigms for metastatic uveal melanoma
por: Patel, Sapna P., et al.
Publicado: (2022)

Ischemia Is Related to Tumour Genetics in Uveal Melanoma
por: Brouwer, Niels J., et al.
Publicado: (2019)

Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
por: Harbour, J. William, et al.
Publicado: (2013)

Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma
por: Waninger, Jessica J., et al.
Publicado: (2022)

Molecular profiling of driver events in metastatic uveal melanoma
por: Karlsson, Joakim, et al.
Publicado: (2020)

Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
por: Demirci, Hakan, et al.
Publicado: (2013)

Improving therapy in metastatic uveal melanoma by understanding prior failures
por: Olson, Daniel J., et al.
Publicado: (2020)

Tracing the evolution of aneuploid cancers by multiregional sequencing with CRUST
por: Chattopadhyay, Subhayan, et al.
Publicado: (2021)

The genetics of uveal melanoma: current insights
por: Helgadottir, Hildur, et al.
Publicado: (2016)

Genetics and RNA Regulation of Uveal Melanoma
por: Barbagallo, Cristina, et al.
Publicado: (2023)

Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
por: Mignard, Claire, et al.
Publicado: (2018)

Pembrolizumab as first-line treatment for metastatic uveal melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Identification of novel chemotherapeutic strategies for metastatic uveal melanoma
por: Fagone, Paolo, et al.
Publicado: (2017)

The Role of HGF/MET Signaling in Metastatic Uveal Melanoma
por: Tanaka, Ryota, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0vsfv6lum7tf555ko24uio9u66